Next Article in Journal
Fanconi Anaemia, Childhood Cancer and the BRCA Genes
Next Article in Special Issue
Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree
Previous Article in Journal
Drosophila Models for Charcot–Marie–Tooth Neuropathy Related to Aminoacyl-tRNA Synthetases
Previous Article in Special Issue
Using Paramecium as a Model for Ciliopathies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 12
Issue 10
10.3390/genes12101518
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Catalogue for Transmission Genetics in Arabs (CTGA) Database: Analysing Lebanese Data on Genetic Disorders

by
Sami Bizzari
1,†,
Pratibha Nair
1,†,
Asha Deepthi
1,
Sayeeda Hana
1,
Mahmoud Taleb Al-Ali
1,
André Megarbané
2 and
Stephany El-Hayek
1,*
1
Centre for Arab Genomic Studies, Dubai 22252, United Arab Emirates
2
Department of Human Genetics, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut 13-5053, Lebanon
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Genes 2021, 12(10), 1518; https://doi.org/10.3390/genes12101518
Submission received: 7 September 2021 / Revised: 21 September 2021 / Accepted: 25 September 2021 / Published: 27 September 2021
(This article belongs to the Special Issue Genetics of Rare Disease)
Browse Figures
Review Reports Versions Notes

Abstract

:
Lebanon has a high annual incidence of birth defects at 63 per 1000 live births, most of which are due to genetic factors. The Catalogue for Transmission Genetics in Arabs (CTGA) database, currently holds data on 642 genetic diseases and 676 related genes, described in Lebanese subjects. A subset of disorders (14/642) has exclusively been described in the Lebanese population, while 24 have only been reported in CTGA and not on OMIM. An analysis of all disorders highlights a preponderance of congenital malformations, deformations and chromosomal abnormalities and demonstrates that 65% of reported disorders follow an autosomal recessive inheritance pattern. In addition, our analysis reveals that at least 58 known genetic disorders were first mapped in Lebanese families. CTGA also hosts 1316 variant records described in Lebanese subjects, 150 of which were not reported on ClinVar or dbSNP. Most variants involved substitutions, followed by deletions, duplications, as well as in-del and insertion variants. This review of genetic data from the CTGA database highlights the need for screening programs, and is, to the best of our knowledge, the most comprehensive report on the status of genetic disorders in Lebanon to date.

1. Introduction

Lebanon is a Levantine country, located on the Mediterranean Sea. Although a small country, with a total area of 10,452 km2, its location on the crossroad of both land and maritime routes has provided it with great historical and cultural significance since antiquity. The total population in Lebanon is currently estimated at 6.8 million people [1]. However, non-Lebanese residents account for almost 30% of this figure, with the massive influx of refugees, mostly from Syria, that the country has witnessed in the past decade [2]. On the other hand, during and following the Lebanese civil war and up until the present, a significant proportion of citizens left the country, contributing to a large Lebanese diaspora (estimated 4–13 million individuals) across the globe, especially concentrated in South America, Canada, and Australia [3].
Genetic disorders are highly prevalent in the Arab World [4,5,6]. Some of the factors contributing to this high prevalence in these populations include the high fertility and birth rates, and the high rates of consanguineous unions [7]. Although lower relative to countries in the Arabian Gulf and North Africa, Lebanon still has a high annual incidence of birth defects at 63 per 1000 live births; most of these congenital defects being due to genetic factors [4]. Genetic disorders in Lebanon have been overviewed by Nakouzi et al., Khneisser et al., and earlier by Der Kaloustian [8,9,10].
The Catalogue for Transmission Genetics in Arabs (CTGA) database, hosted online at https://cags.org.ae/ (accessed on 29 July 2021), is a compendium of bibliographic data on genetic disorders in Arabs, compiled and curated through searches on PubMed and Index Medicus [11]. To date, CTGA is the only database documenting Arab genomic variation which is entirely manually curated. In this review, we present a report of genetic disorders and associated gene variants in the Lebanese population pulled from the CTGA database. This is, to the best of our knowledge, the most comprehensive review on the status of genetic disorders in this country.

2. Materials and Methods

We conducted a comprehensive literature search on PubMed for biomedical literature either originating from Lebanon or referring to Lebanese subjects, using the search string “Lebanon* OR Lebanese*”, up to the end of 2020. The 22,159 articles thus obtained were manually screened according to the following inclusion criteria: (a) article describing a genetic disease in a Lebanese individual(s) or subject(s) of Lebanese origin, (b) article describing gene variant(s) in a Lebanese individual or in the Lebanese population, and (c) article reporting a disorder, not commonly known to be genetic, in multiple members of a Lebanese family. The following categories of articles were excluded: (a) articles carrying information only on non-Lebanese subjects, (b) articles carrying redundant data. The 814 screened articles were then carefully analyzed and information on the genetic disorder, relevant HPO terms, and gene variants reported in anonymous Lebanese subjects were manually extracted and added to the CTGA database (Figure 1A).
CTGA is an SQL database containing five related categories of records: disease, gene, variant, subject, and reference article. Disease and gene records are linked to their corresponding OMIM records, whenever available. Published variants for which HGVS reference sequence positions were identifiable were entered into CTGA as distinct records and linked to relevant subjects. These variants are linked to their dbSNP and ClinVar records, if available. Data on other variants were incorporated in text descriptions in relevant gene and disease records, but not as separate variant records. Anonymous subject records contain HPO terms and are linked to the relevant published article reference. Data can be accessed through a simple or advanced search.

3. Results and Discussion

Although genetic publications on Lebanese subjects started as early as 1950 [12], it is only after the late 1990s, following the end of the Lebanese civil war, that we see a significant amount of genetic literature being published. An earlier study analyzing the biomedical bibliometric output from Lebanon until 2007 showed an increasing trend for publications [13]. We see a similar trend in publications over the years in our analysis of year-wise distribution of the selected articles, signifying an increase in genetic research. We were also interested in monitoring the evolution of medical genetic studies, especially with the advent of newer molecular technologies. The percentage of research articles with available molecular data shows a clear increasing trend, especially over the last decade (Figure 1B), corresponding to the time period when NGS techniques were adopted by clinicians in Lebanon for the diagnosis of genetic diseases. Interestingly, the number of such publications declined in the past couple of years, likely due to the economic crisis that Lebanon has since been facing.
The CTGA database currently holds data on 642 genetic diseases, 676 related genes, and 1316 variants described in the Lebanese population. Of all diseases, 24 are genetic and/or congenital disorders that are not available on OMIM (Table 1). Almost all of these are syndromic conditions, with a combination of clinical features not described elsewhere. For instance, variants of MCA/MR (multiple congenital anomalies/mental retardation) conditions with new constellations of features [14,15], novel phenotypes associated with genes known to cause other related genetic diseases [16,17], and other syndromic congenital disorders [18,19]. The absence of these disorders in other genetic databases like OMIM points to the rarity of these conditions. Our review also revealed 14 rare genetic disorders that have exclusively been described in the Lebanese population (Table 1). These include the Lebanese type of Mannose 6-Phosphate Receptor Recognition Defect (MIM # 154570), a form of autosomal recessive deafness (MIM # 603678), as well as a form of autosomal recessive dystonia (MIM # 612406). Two factors in combination could be responsible for the presence of this relatively large number of genetic conditions in this population. The first is the availability of and access to trained geneticists capable of recognizing and diagnosing these conditions, despite a relatively low grade medical and genetic infrastructure in the country [8]. The second factor is the persistent relatively increased prevalence of consanguineous marriages, resulting in the manifestation of rare disorders, many of which follow a recessive mode of inheritance [20]. In fact, around 65% of diseases we report in Lebanese subjects on CTGA follow an autosomal recessive inheritance pattern (Figure 2). This is in line with the numbers reported in 2015 [8]. Disorders following an autosomal dominant inheritance pattern make up about 26% of all reports, followed by X-linked and mitochondrial disorders.
We categorized the genetic disorders in the Lebanese population based on the WHO ICD-10 classification criteria (Figure 3). The most common category of disorders is congenital malformations, deformations and chromosomal abnormalities, followed by endocrine, nutritional and metabolic diseases and diseases of the nervous system. This pattern is comparable to data from other Arab countries in the CTGA database [21]. The overwhelming predominance of congenital malformations points to the large number of monogenic syndromic disorders in the database. Most of these disorders are relatively rare, with prevalence rates of less than 1 in 100,000. In fact, 314/394 (79.6%) Lebanese genetic disorders with known prevalence rates are rare, with rates less than 10 in 100,000. On the other hand, based on limited studies, certain disorders, including Fanconi anemia (MIM # 227650), alpha/beta thalassemia (MIM # 604131; MIM # 613985), and familial hypercholesterolemia (MIM # 143890), have been reported to have high prevalence rates [22,23,24,25]. Analyzing CTGA entries also allows us to note several rare disorders with a remarkably high occurrence among Lebanese subjects. For instance, odontoonychodermal dysplasia (MIM # 257980) and Dyggve-Melchior-Clausen syndrome (MIM # 223800) have each been identified in eight different families to date, while 15 unrelated families have been reported with Berardinelli-Seip congenital lipodystrophy type 2 (MIM # 269700). In its various forms, predominantly type 1A (MIM # 220290), recessive deafness has been reported in subjects from over 30 Lebanese families. The presence of such rare genetic disorders, especially in large consanguineous kindreds, is very useful in the mapping of the causative loci and the identification of the causal gene [26,27,28]. In fact, our survey on the Lebanese population identified 58 separate genetic disorders that were first mapped in Lebanese families (Table 1). Despite this, 62 of the disorders reported in Lebanon in the CTGA Database remain unmapped.
We collated the clinical features of all Lebanese subjects in the CTGA Database (Table 2). Individual patients and familial studies frequently reported intellectual disability, developmental delay, short stature, hearing impairment, muscular hypotonia etc., highlighting the role of congenital malformations, in accordance with our ICD-10 classification. In contrast, an analysis of clinical manifestations in studies involving large groups of patients, mostly comprising association studies, brings out the impact of multifactorial and polygenic disorders that are common in the population (Table 2). For instance, diabetes, hypercholesterolemia, coronary artery disease, and neoplasms feature prominently.
The most recent review of genetic disorders on Lebanon which surveyed CTGA, OMIM, and the literature reported a total of 378 diseases reported in individuals of Lebanese origin [8]. In a preliminary 2017 CTGA analysis, only about half of these reported diseases had been molecularly diagnosed. In the current study, 78% of the 642 diseases we report have a molecular diagnosis. This rise in the number of reported diseases as well as in percentage of molecularly diagnosed cases is likely due to the increased adoption of NGS by Lebanese clinics/diagnostic centers. In addition, from our own experience, revisiting NGS data has helped in identifying causal variants of previously undiagnosed cases [29]. However, there remain 131 diseases out of the 642 total diseases we report here from CTGA wherein the Lebanese subjects lack a molecular diagnosis. The vast majority of these 131 disorders (82%) contain purely clinical descriptions or reports with no molecular study attempted.
To date, CTGA hosts a total of 1316 variant records described in Lebanese subjects. The majority of variants entered into CTGA expectedly involved substitutions, followed by deletions, duplications, as well as in-del and insertion variants. Less frequently reported variants included haplotypes, involving up to three variants on one allele, and microsatellites (Figure 4A). Variant records were added to CTGA and screened against dbSNP and ClinVar variant databases, revealing 150 CTGA-exclusive variants (Supplementary Table S2), 840 with both dbSNP and ClinVar records, 274 with dbSNP records, and 28 with ClinVar records (Figure 4B). Additionally, 222 variants were described in text summaries in disease and gene records, with over half of these involving copy number variations (54.8%), and the remaining entries reporting linkage studies, unspecified/whole gene deletions, gene rearrangements, inversions, as well as karyotypes. HLA and KIR alleles, as well as Gm and MHC class III allele variants were excluded from this count.
A more detailed look at the individual variants reported reveals several interesting results. The first of these is the presence of high prevalence variants reported in subjects of Lebanese origin. One such example is the p.Met1Ile mutation (rs587777839) in PET100. The latter has been identified in over 31 subjects exclusively from 12 different Lebanese families to date [30,31,32,33]. Another variant to note is the well-known p.Cys681X variant in the LDLR gene (rs121908031). Although it has been identified in various Arab and non-Arab nationalities, this variant, associated with Familial Hypercholesterolemia 1 (MIM # 143890), has been termed the Lebanese allele because of its high frequency in the Lebanese population [34,35] and even the Lebanese diaspora [36,37,38]. Evidence points towards founder mutation events driving the increased prevalence of these two variants.
Another category of variants are those that, although have been reported in non-Arab subjects, have so far only been reported in Lebanese subjects among Arabs in CTGA. For instance, a mutation in SLC52A2 (rs398124641) leading to Brown-Vialetto-Van Laere Syndrome 2 (MIM # 614707) has been identified in two large unrelated Lebanese consanguineous families [39,40]. Another in BSCL2 (rs587777608) has been reported in five unrelated Lebanese families with Congenital Generalized Lipodystrophy 2 (MIM # 269700) [41,42]. A p.Met1Val mutation in DMP1 (rs104893834), associated with Autosomal Recessive Hypophosphatemic Rickets 1 (MIM # 241520) has been described in 14 subjects from at least three different Lebanese families [43,44,45].
Repositories of population specific genetic variants are crucial in providing clinical interpretations of these variants for both rare and common genetic disorders [46]. This is especially true for Arab nations which are burdened with a high incidence of rare genetic disorders and occurrence of founder mutations within their populations. Unfortunately, the Middle Eastern population is represented poorly in global variation databases, such as the Genome Aggregation Database [47]. Through continuous updates since its first release in 2005, CTGA is now the largest compendium of clinical genomic variants in Arab populations. Despite only hosting bibliographic data, 13% of the Lebanese variants within it are not found in either dbSNP or Clinvar, indicating its value for clinicians and researchers who deal with Arab patients (Supplementary Table S2).
CTGA is freely accessible online and researchers are encouraged to make use of the data available within it. As an example, here we show the type of data on ciliopathies in Lebanon that can be accessed from the database. CTGA contains information on 31 different ciliopathies that have been diagnosed in Lebanese subjects. These include several subtypes of Bardet-Beidl Syndrome, Leber Congenital Amaurosis and Usher Syndrome (Supplementary Table S3). Some of these ciliopathies are disorders that were first mapped in Lebanese families, such as Orofaciodigital Syndrome XIV (MIM # 615948), Short-Rib Thoracic Dysplasia 14 with Polydactyly (MIM # 616546), and Bardet-Biedl Syndrome 10, (MIM # 615987) [48,49,50]. On the other hand, the database also contains reports of rare ciliopathies in Lebanese subjects that are yet to be mapped, such as Ciliary Discoordination due to Random Ciliary Orientation (MIM # 215518) and Rhizomelic Dysplasia, Scoliosis, and Retinitis Pigmentosa (MIM # 610319) [51,52]. Of the 676 genes studied in Lebanese subjects, 28 (4.1%), carrying a total of 45 variants, are genes related to ciliopathies (Supplementary Table S3). Notably, seven of these variants, associated with subtypes of LCA, BBS, and Usher Syndrome, were absent from dbSNP and ClinVar.

4. Conclusions

In this report, we have attempted to provide an overview of the status of genetic disorders in Lebanon. High levels of consanguinity have been shown time and again to correlate with the spread of rare recessive disorders through inbred kindreds, especially in Arab populations [27,53,54,55]. In Lebanon, the relatively high level of consanguinity, coupled with a severe lack of genetic infrastructure within the country [8], has serious implications for the diagnosis and treatment of families affected with genetic disorders. There is thus an immediate need to both increase awareness among the general population on the consequences of inbreeding and familial genetic disorders, as well as to build advanced molecular diagnostic facilities. Simultaneously, despite improvement over the past 20 years, active effort needs to be made towards building an environment that further provides support for clinical research.
Population level screening programs are still in their infancy in Lebanon. Although privately operated neonatal screening programs exist, they are estimated to cover less than half of the newborn population [56]. At the same time, rare disease registries that can offer valuable insights to clinicians, pharmaceutical companies and families of affected patients are non-existent. Efforts towards initiating a comprehensive public neonatal screening program and establishing rare disease registries could go a long way towards reducing the burden of genetic disorders in the country.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/genes12101518/s1, Table S1: List of all disorders reported in Lebanese subjects on CTGA, with their OMIM numbers and associated genes where applicable, as well as mode of inheritance and WHO ICD-10 classification, Table S2: List of variants reported in Lebanese subjects in CTGA, but not in ClinVar or dbSNP, Table S3: List of ciliopathies, related genes and gene variants described in Lebanese subjects in CTGA.

Author Contributions

All authors have made substantial contributions to conception and design of the study. S.B., P.N., A.D., S.H., A.M. and S.E.-H. have made substantial contributions in acquisition of data, analysis and interpretation of data. S.B., P.N., A.D., S.H., M.T.A.-A., A.M. and S.E.-H. have been involved in the writing of the original manuscript and revising it critically, where S.B and P.N have contributed equally. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical review and approval were waived for this study, due to the bibliographic nature of the data analyzed and described in this report.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data reported and analyzed in this study can be found at www.cags.org.ae/ctga-search.

Acknowledgments

We thank Eliane Chouery and Cybel Mehawej for their valuable input during the preparation of this manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. UNPFA. World Population Dashboard: Lebanon. Available online: https://www.unfpa.org/data/world-population/LB (accessed on 23 August 2021).
  2. UNHCR. 2020 Year-End Results. Available online: https://reporting.unhcr.org/lebanon (accessed on 23 August 2021).
  3. Tabar, P.; Denison, A. Diaspora Policies, Consular Services and Social Protection for Lebanese Citizens Abroad. In Migration and Social Protection in Europe and Beyond (Volume 3): A Focus on Non-EU Sending States; Lafleur, J.-M., Vintila, D., Eds.; Springer International Publishing: Cham, Germany, 2020; pp. 199–215. [Google Scholar]
  4. Christianson, A.; Howson, C.P.; Modell, B. March of Dimes: Global Report on Birth Defects; March of Dimes Birth Defects Foundation: White Plains, NY, USA, 2006. [Google Scholar]
  5. Al-Gazali, L.; Hamamy, H.; Al-Arrayad, S. Genetic disorders in the Arab world. BMJ 2006, 333, 831–834. [Google Scholar] [CrossRef] [Green Version]
  6. Der Kaloustian, V.M. Genetic Disorders in Lebanon. In Genetic Disorders among Arab Populations; Teebi, A.S., Ed.; Springer: Berlin/Heidelberg, Germany, 2010; pp. 377–441. [Google Scholar]
  7. Al-Gazali, L.; Hamamy, H. Consanguinity and dysmorphology in Arabs. Hum. Hered. 2014, 77, 93–107. [Google Scholar] [CrossRef]
  8. Nakouzi, G.; Kreidieh, K.; Yazbek, S. A review of the diverse genetic disorders in the Lebanese population: Highlighting the urgency for community genetic services. J. Community Genet. 2015, 6, 83–105. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Issam Khneisser, S.M.A.; Megarbane, A. Genetic Disorders in Lebanon: Challenges and Opportunities. In Genomics and Health in the Developing World; Kumar, D., Ed.; Oxford University Press: Oxford, UK, 2012. [Google Scholar]
  10. Der Kaloustian, V.M. Genetic diseases in Lebanon. Am. J. Med. Genet. 1986, 36, 65–68. [Google Scholar] [CrossRef]
  11. CAGS. Catalogue for Transmission Genetics in Arabs Database. Available online: https://cags.org.ae/en/ctga-overview (accessed on 23 August 2021).
  12. Pipkin, A.C.; Pipkin, S.B. A pedigree of generalized lentigo. J. Hered. 1950, 41, 79–82. [Google Scholar] [CrossRef] [PubMed]
  13. Bissar-Tadmouri, N.; Tadmouri, G.O. Bibliometric analyses of biomedical research outputs in Lebanon and the United Arab Emirates (1988–2007). Saudi Med. J. 2009, 30, 130–139. [Google Scholar] [PubMed]
  14. Megarbane, A.; Ghanem, I.; Romana, S.; Gosset, P.; Caillaud, C. Congenital contractures, short stature, abnormal face, microcephaly, scoliosis, hip dislocation, and severe psychomotor retardation in two unrelated girls. A new MCA/MR syndrome? Genet. Couns. 2002, 13, 123–131. [Google Scholar] [PubMed]
  15. Megarbane, A.; Haddad-Zebouni, S.; Nabbout, R.; Khoury, A.H.; Traboulsi, E.I. Microcephaly, colobomatous microphthalmia, short stature, and severe psychomotor retardation in two male cousins: A new MCA/MR syndrome? Am. J. Med. Genet. 1999, 83, 82–87. [Google Scholar] [CrossRef]
  16. Wakim, V.; Nair, P.; Delague, V.; Bizzari, S.; Al-Ali, M.T.; Castro, C.; Alicia, G.; Stephany, E.-H.; André, M.M. SOX11-related syndrome: Report on a new case and review. Clin. Dysmorphol. 2021, 30, 44–49. [Google Scholar] [CrossRef]
  17. Hana, S.; Karthik, D.; Shan, J.; El Hayek, S.; Chouchane, L.; Megarbane, A. A Report on a Family with TMTC3-Related Syndrome and Review. Case Rep. Med. 2020, 2020, 7163038. [Google Scholar] [CrossRef]
  18. Bizzari, S.; El-Bazzal, L.; Nair, P.; Younan, A.; Stora, S.; Mehawej, C.; El-Hayek, S.; Delague, V.; Mégarbané, A. Recessive marfanoid syndrome with herniation associated with a homozygous mutation in Fibulin-3. Eur. J. Med. Genet. 2020, 63, 103869. [Google Scholar] [CrossRef] [PubMed]
  19. Megarbane, A.; Rassi, S.; Estephan, F.; Kouba-Hreich, E. Post-natal short stature, short limbs, brachydactyly, facial abnormalities, and delayed bone age: A new syndrome? Am. J. Med. Genet. Part A 2004, 125A, 57–60. [Google Scholar] [CrossRef]
  20. Oniya, O.; Neves, K.; Ahmed, B.; Konje, J.C. A review of the reproductive consequences of consanguinity. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019, 232, 87–96. [Google Scholar] [CrossRef] [PubMed]
  21. Nair, P.; Obaid, T.; Tadmouri, G.O. Genetic Disorders in Qatar: A CTGA Perspective. In Genetic Disorders in the Arab World: Qatar; Taleb Al Ali, M., Ed.; CAGS: Dubai, United Arab Emirates, 2012; Volume 4. [Google Scholar]
  22. Farah, R.A.; Nair, P.; Koueik, J.; Yammine, T.; Khalifeh, H.; Korban, R.; Agnes, C.; Claudia, K.; Catherine, D.-D.; Eliane, C.; et al. Clinical and Genetic Features of Patients with Fanconi Anemia in Lebanon and Report on Novel Mutations in the FANCA and FANCG Genes. J. Pediatr. Hematol./Oncol. 2021, 43, e727–e735. [Google Scholar] [CrossRef] [PubMed]
  23. Farra, C.; Badra, R.; Fares, F.; Muwakkit, S.; Dbaibo, G.; Dabbous, I.; Ashkar, H.; Mounsef, C.; Abboud, M.R. Alpha thalassemia allelic frequency in Lebanon. Pediatr. Blood Cancer 2015, 62, 120–122. [Google Scholar] [CrossRef] [PubMed]
  24. Inati, A.; Zeineh, N.; Isma’eel, H.; Koussa, S.; Gharzuddine, W.; Taher, A. Beta-thalassemia: The Lebanese experience. Clin. Lab. Haematol. 2006, 28, 217–227. [Google Scholar] [CrossRef] [PubMed]
  25. Jelwan, Y.A.; Asbeutah, A.A.A.; Welty, F.K. Comprehensive Review of Cardiovascular Diseases, Diabetes, and Hypercholesterolemia in Lebanon. Cardiol. Rev. 2020, 28, 73–83. [Google Scholar] [CrossRef] [PubMed]
  26. Maddirevula, S.; Shamseldin, H.E.; Sirr, A.; AlAbdi, L.; Lo, R.S.; Ewida, N.; Al-Qahtani, M.; Hashem, M.; Abdulwahab, F.; Aboyousef, O.; et al. Exploiting the Autozygome to Support Previously Published Mendelian Gene-Disease Associations: An Update. Front. Genet. 2020, 11, 580484. [Google Scholar] [CrossRef]
  27. Romdhane, L.; Mezzi, N.; Hamdi, Y.; El-Kamah, G.; Barakat, A.; Abdelhak, S. Consanguinity and Inbreeding in Health and Disease in North African Populations. Annu. Rev. Genom. Hum. Genet. 2019, 20, 155–179. [Google Scholar] [CrossRef]
  28. Alkuraya, F.S. Autozygome decoded. Genet. Med. 2010, 12, 765–771. [Google Scholar] [CrossRef]
  29. Megarbane, A. Clinical genetics revisited: Effect of new techniques (next-generation sequencing, comparative genomic hybridization) on previous diagnoses. Middle East. J. Med. Genet. 2018, 7, 1–6. [Google Scholar]
  30. Lim, S.C.; Smith, K.R.; Stroud, D.; Compton, A.; Tucker, E.; Dasvarma, A.; Gandolfo, L.C.; Marum, J.E.; McKenzie, M.; Peters, H.L.; et al. A founder mutation in PET100 causes isolated complex IV deficiency in Lebanese individuals with Leigh syndrome. Am. J. Hum. Genet. 2014, 94, 209–222. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Jalkh, N.; Corbani, S.; Haidar, Z.; Hamdan, N.; Farah, E.; Abou Ghoch, J.; Ghosn, R.; Salem, N.; Fawaz, A.; Khayat, C.D.; et al. The added value of WES reanalysis in the field of genetic diagnosis: Lessons learned from 200 exomes in the Lebanese population. BMC Med. Genom. 2019, 12, 11. [Google Scholar] [CrossRef] [Green Version]
  32. Mansour, H.; Sabbagh, S.; Bizzari, S.; El-Hayek, S.; Chouery, E.; Gambarini, A.; Gencik, M.; Mégarbané, A. The Lebanese Allele in the PET100 Gene: Report on Two New Families with Cytochrome c Oxidase Deficiency. J. Pediatr. Genet. 2019, 8, 172–178. [Google Scholar] [CrossRef]
  33. Riley, L.G.; Cowley, M.J.; Gayevskiy, V.; Minoche, A.E.; Puttick, C.; Thorburn, D.; Rius, R.; Compton, A.; Menezes, M.J.; Bhattacharya, K.; et al. The diagnostic utility of genome sequencing in a pediatric cohort with suspected mitochondrial disease. Genet. Med. 2020, 22, 1254–1261. [Google Scholar] [CrossRef]
  34. Fahed, A.C.; Safa, R.M.; Haddad, F.F.; Bitar, F.F.; Andary, R.R.; Arabi, M.T.; Azar, S.T.; Nemer, G. Homozygous familial hypercholesterolemia in Lebanon: A genotype/phenotype correlation. Mol. Genet. Metab. 2011, 102, 181–188. [Google Scholar] [CrossRef] [PubMed]
  35. Fahed, A.C.; Bitar, F.F.; Khalaf, R.I.; Moubarak, E.M.; Azar, S.T.; Nemer, G.M. The Lebanese allele at the LDLR in normocholesterolemic people merits reconsideration of genotype phenotype correlations in familial hypercholesterolemia. Endocrine 2012, 42, 445–448. [Google Scholar] [CrossRef]
  36. Dos Santos, J.E.; Zago, M.A. Familial hypercholesterolemia in Brazil. Atheroscler. Suppl. 2003, 4, 1–2. [Google Scholar] [CrossRef]
  37. Fahed, A.C.; Khalaf, R.; Salloum, R.; Andary, R.R.; Safa, R.; El-Rassy, I.; Moubarak, E.; Azar, S.T.; Bitar, F.F.; Nemer, G. Variable expressivity and co-occurrence of LDLR and LDLRAP1 mutations in familial hypercholesterolemia: Failure of the dominant and recessive dichotomy. Mol. Genet. Genom. Med. 2016, 4, 283–291. [Google Scholar] [CrossRef] [Green Version]
  38. Fahed, A.C.; Shibbani, K.; Andary, R.R.; Arabi, M.T.; Habib, R.H.; Nguyen, D.D.; Haddad, F.F.; Moubarak, E.; Nemer, G.; Azar, S.T.; et al. Premature Valvular Heart Disease in Homozygous Familial Hypercholesterolemia. Cholesterol 2017, 2017, 3685265. [Google Scholar] [CrossRef] [Green Version]
  39. Johnson, J.O.; Gibbs, J.R.; Megarbane, A.; Urtizberea, J.A.; Hernandez, D.G.; Foley, A.R.; Arepalli, S.; Pandraud, A.; Simón-Sánchez, J.; Clayton, P.; et al. Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain 2012, 135, 2875–2882. [Google Scholar] [CrossRef] [PubMed]
  40. Srour, M.; Putorti, M.L.; Schwartzentruber, J.; Bolduc, V.; Shevell, M.I.; Poulin, C.; O’ferrall, E.; Buhas, D.; Majewski, J.; Brais, B. Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood. Muscle Nerve 2014, 50, 775–779. [Google Scholar] [CrossRef] [PubMed]
  41. Agarwal, A.K.; Simha, V.; Oral, E.A.; Moran, S.A.; Gorden, P.; O’Rahilly, S.; Zaidi, Z.; Gurakan, F.; Arslanian, S.A.; Klar, A.; et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 2003, 88, 4840–4847. [Google Scholar] [CrossRef]
  42. Van Maldergem, L.; Magre, J.; Khallouf, T.E.; Gedde-Dahl, T.; Delépine, M.; Trygstad, O.; Seemanova, E.; Stephenson, T.; Albott, C.S.; Bonnici, F.; et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J. Med. Genet. 2002, 39, 722–733. [Google Scholar] [CrossRef] [PubMed]
  43. Feng, J.Q.; Ward, L.M.; Liu, S.; Lu, Y.B.; Xie, Y.X.; Yuan, B.Z.; Yu, X.J.; Rauch, F.; Davis, S.I.; Zhang, S.B.; et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 2006, 38, 1310–1315. [Google Scholar] [CrossRef]
  44. Gannage-Yared, M.H.; Makrythanasis, P.; Chouery, E.; Sobacchi, C.; Mehawej, C.; Santoni, F.A.; Guipponi, M.; Antonarakis, S.E.; Hamamy, H.; Mégarbané, A. Exome sequencing reveals a mutation in DMP1 in a family with familial sclerosing bone dysplasia. Bone 2014, 68, 142–145. [Google Scholar] [CrossRef]
  45. Lorenz-Depiereux, B.; Bastepe, M.; Benet-Pages, A.; Amyere, M.; Wagenstaller, J.; Müller-Barth, U.; Badenhoop, K.; Kaiser, S.M.; Rittmaster, R.S.; Shlossberg, A.H.; et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat. Genet. 2006, 38, 1248–1250. [Google Scholar] [CrossRef]
  46. Lek, M.; Karczewski, K.J.; Minikel, E.V.; Samocha, K.E.; Banks, E.; Fennell, T.; O’Donnell-Luria, A.H.; Ware, J.S.; Hill, A.J.; Cummings, B.B.; et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016, 536, 285–291. [Google Scholar] [CrossRef] [Green Version]
  47. Abou Tayoun, A.N.; Rehm, H.L. Genetic variation in the Middle East-an opportunity to advance the human genetics field. Genome Med. 2020, 12, 116. [Google Scholar] [CrossRef]
  48. Thauvin-Robinet, C.; Lee, J.S.; Lopez, E.; Herranz-Pérez, V.; Shida, T.; Franco, B.; Jego, L.; Ye, F.; Pasquier, L.; Loget, P.; et al. The oral-facial-digital syndrome gene C2CD3 encodes a positive regulator of centriole elongation. Nat. Genet. 2014, 46, 905–911. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Alby, C.; Piquand, K.; Huber, C.; Megarbané, A.; Ichkou, A.; Legendre, M.; Pelluard, F.; Encha-Ravazi, F.; Abi-Tayeh, G.; Bessières, B.; et al. Mutations in KIAA0586 Cause Lethal Ciliopathies Ranging from a Hydrolethalus Phenotype to Short-Rib Polydactyly Syndrome. Am. J. Hum. Genet. 2015, 97, 311–318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Stoetzel, C.; Laurier, V.; Davis, E.E.; Muller, J.; Rix, S.; Badano, J.L.; Leitch, C.C.; Salem, N.; Chouery, E.; Corbani, S.; et al. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat. Genet. 2006, 38, 521–524. [Google Scholar] [CrossRef] [PubMed]
  51. Rutland, J.; de Iongh, R.U. Random ciliary orientation. A cause of respiratory tract disease. N. Eng. J. Med. 1990, 323, 1681–1684. [Google Scholar] [CrossRef] [PubMed]
  52. Megarbane, A.; Ghanem, I.; Waked, N.; Dagher, F. A newly recognized autosomal recessive syndrome with short stature and oculo-skeletal involvement. Am. J. Med. Genet. Part A 2006, 140, 1491–1496. [Google Scholar] [CrossRef] [PubMed]
  53. Singer, S.; Davidovitch, N.; Abu Fraiha, Y.; Abu Freha, N. Consanguinity and genetic diseases among the Bedouin population in the Negev. J. Community Genet. 2020, 11, 13–19. [Google Scholar] [CrossRef] [PubMed]
  54. Afzal, R.M.; Lund, A.M.; Skovby, F. The impact of consanguinity on the frequency of inborn errors of metabolism. Dan. Med. J. 2018, 65, 6–10. [Google Scholar] [CrossRef] [PubMed]
  55. Alkuraya, F.S. Impact of new genomic tools on the practice of clinical genetics in consanguineous populations: The Saudi experience. Clin. Genet. 2013, 84, 203–208. [Google Scholar] [CrossRef] [PubMed]
  56. Khneisser, I.; Adib, S.; Assaad, S.; Megarbane, A.; Karam, P. Cost-benefit analysis: Newborn screening for inborn errors of metabolism in Lebanon. J. Med. Screen. 2015, 22, 182–186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Genes 12 01518 g001 550
Figure 1. Bibliographic review of papers with Lebanese subjects. (A) Flowchart detailing criteria of study selection (B) Number of final selected publications (1991–2020) with and without molecular data classed by year of publication. Trendline is based on the number of molecular studies per year.
Figure 1. Bibliographic review of papers with Lebanese subjects. (A) Flowchart detailing criteria of study selection (B) Number of final selected publications (1991–2020) with and without molecular data classed by year of publication. Trendline is based on the number of molecular studies per year.
Genes 12 01518 g001
Genes 12 01518 g002 550
Figure 2. Distribution of mode of inheritance of diseases reported in Lebanese subjects in CTGA.
Figure 2. Distribution of mode of inheritance of diseases reported in Lebanese subjects in CTGA.
Genes 12 01518 g002
Genes 12 01518 g003 550
Figure 3. WHO ICD-10 classification of diseases reported in Lebanese subjects in CTGA. X-axis denotes number of disease entries in each class.
Figure 3. WHO ICD-10 classification of diseases reported in Lebanese subjects in CTGA. X-axis denotes number of disease entries in each class.
Genes 12 01518 g003
Genes 12 01518 g004 550
Figure 4. CTGA variant records reported in Lebanese subjects. (A) Distribution of types of 1316 CTGA variant records reported in Lebanese subjects. (B) Cylinder Venn distribution of CTGA variant records reported in Lebanese subjects relative to dbSNP and ClinVar variant databases (last updated 14 June 2021). * 24 of the 1316 variants were omitted due to disparate modes of classification between dbSNP and ClinVar, involving multiple distinct variants at the same position as well as haplotypes.
Figure 4. CTGA variant records reported in Lebanese subjects. (A) Distribution of types of 1316 CTGA variant records reported in Lebanese subjects. (B) Cylinder Venn distribution of CTGA variant records reported in Lebanese subjects relative to dbSNP and ClinVar variant databases (last updated 14 June 2021). * 24 of the 1316 variants were omitted due to disparate modes of classification between dbSNP and ClinVar, involving multiple distinct variants at the same position as well as haplotypes.
Genes 12 01518 g004
Table
Table 1. List of selected diseases in the CTGA Database with Lebanese subjects. Rows marked with * indicate diseases reported exclusively in Lebanese subjects. Rows marked with # indicate diseases that were first mapped in Lebanese subjects. Complete list of records is available in Supplementary Table S1.
Table 1. List of selected diseases in the CTGA Database with Lebanese subjects. Rows marked with * indicate diseases reported exclusively in Lebanese subjects. Rows marked with # indicate diseases that were first mapped in Lebanese subjects. Complete list of records is available in Supplementary Table S1.
NamePhenotype OMIM NumberRelated Gene RecordGene/Locus OMIM Number
Diseases on CTGA not on OMIM (numbers in parentheses denote number of patients described)
Brachytelephalangy with Mental Retardation, Peculiar Face and Short Stature (1 family, 2 patients)
Congenital Contractures, Short Stature, Abnormal Face, Microcephaly, Scoliosis, Hip Dislocation, and Severe Psychomotor Retardation (2 families, 2 patients)
Craniosynostosis, Telecanthus, Scalp Hair Abnormalities, and Sensorineural Deafness (1 family, 2 patients)
Discoid Lupus Erythematosus (1 family, 4 patients) TRAF3IP3607043
Intellectual Deficiency, Unclassified (at least 147 patients)
Linear and Whorled Nevoid Hypermelanosis with Cerebral Aneurysms (1 family, 1 patient)
Marfanoid Habitus-Inguinal Hernia-Advanced Bone Age Syndrome (1 family, 2 patients) EFEMP1601548
Microcephaly, Colobomatous Micropthalmia, and mental Retardation (1 family, 2 patients)
Multiple Anomalies, Mental Retardation, Megarbane-Le Merrer-El Kallab Type (1 family, 3 patients)
Multiple Congenital Anomalies, Megarbane-Rassi Type (1 family, 1 patient)
Multiple Congenital Anomalies, Mental Retardation, Ambiguous Genitalia, Microcephaly, Seizures, and Bone Malformations (1 family, 2 patients)
Myeloproliferative Disorder, Unclassified (group of 69 patients) JAK2147796
Ptosis, Mental Retardation and 2/3 Toes Syndactyly (1 family, 2 patients)
Pure Early-Onset Dementia Without Bone Cysts (1 family, 3 patients) TREM2605086
SOX11-Related Syndrome (1 family, 1 patient) SOX11600898
Tibial and Femoral Hypoplasia with ‘Hook’ Pelvis (1 family, 1 patient)
TMTC3-Related Syndrome (1 family, 2 patients) TMTC3617218
12q24.31 Microdeletion Syndrome (1 family, 2 patients)
8p23.1 Microdeletion Syndrome (1 family, 1 patient)
Subacute Thyroiditis (1 family, 3 patients) HLA-B142830
Chromosome 10p Duplication Syndrome (1 family, 1 patient)
Chromosome 7q Duplication Syndrome (1 family, 1 patient)
Trisomy 17p (1 family, 1 patient)
Chromosome 2p Duplication Syndrome (1 family, 1 patient)
Diseases exclusively reported in Lebanon among Arab countries
Acrodysostosis 2 With or without Hormone Resistance614613PDE4D600129
Alveolar Soft Part Sarcoma606243ASPSCR1; TFE3606236; 314310
Amyotrophy, Hereditary Neuralgic162100SEPT9604061
Arrhythmogenic Right Ventricular Dysplasia, Familial, 11610476DSC2125645
Arrhythmogenic Right ventricular Dysplasia, Familial, 9609040PKP2602861
Atrial Septal Defect 4611363TBX20606061
Atrial Septal Defect 5612794ACTC1102540
Atrial Septal Defect, Secundum, with Various Cardiac and Noncardiac Defects *603642
Bardet-Biedl Syndrome 12615989BBS12610683
Benign Chronic Pemphigus169600ATP2C1604384
Bietti Crystalline Corneoretinal Dystrophy210370CYP4V2608614
Borjeson-Forssman-Lehmann Syndrome301900PHF6300414
Branchiogenic-Deafness Syndrome609166
Brown-Vialetto-Van Laere Syndrome 2 #614707SLC52A2607882
Brunner Syndrome300615MAOA309850
Cardiomyopathy, Dilated, 1KK615248MYPN608517
Cardiomyopathy, Dilated, with Hypergonadotropic Hypogonadism212112
Cataract 11, Multiple Types610623PITX3602669
CDAGS Syndrome603116
Cerebral Creatine Deficiency Syndrome 1300352SLC6A8300036
Char Syndrome169100TFAP2B601601
Ciliary Discoordination due to Random Ciliary Orientation215518
Ciliary Dyskinesia, Primary, 3608644DNAH5603335
Clouston Syndrome129500
Coffin-Siris Syndrome 4614609SMARCA4603254
Combined Oxidative Phosphorylation Deficiency 1 #609060GFM1606639
Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects308050
Cornelia de Lange Syndrome 5300882HDAC8300269
Cutis Laxa, Autosomal Recessive, Type IA 219100ELN; FBLN5130160; 604580
Deafness, Autosomal Recessive 14 *,#603678
Developmental and Epileptic Encephalopathy 13614558SCN8A600702
Developmental and Epileptic Encephalopathy 42617106CACNA1A601011
Developmental And Epileptic Encephalopathy 63617976CPLX1605032
Diamond-Blackfan Anemia 6612561RPL5603634
Diastrophic Dysplasia222600SLC26A2606718
Dislocated Elbows, Bowed Tibias, Scoliosis, Deafness, Cataract, Microcephaly, and Mental Retardation *603133
Dubowitz Syndrome223370
Dystonia 17, Torsion, Autosomal Recessive *,#612406
Dystonia, Childhood-Onset, with Optic Atrophy and Basal Ganglia Abnormalities617282MECR608205
Ectodermal Dysplasia and Neurosensory Deafness224800
Ehlers-Danlos Syndrome, Arthrochalasia Type, 2617821COL1A2120160
Ehlers-Danlos Syndrome, classic type, 1 130000COL1A1; COL5A1120150; 120215
Emery-Dreifuss Muscular Dystrophy 5, Autosomal Dominant612999SYNE2608442
Enterocolitis226150
Epidermodysplasia Verruciformis, Susceptibility to, 2618231TMC8605829
Epidermolysis Bullosa with Congenital Localized Absence of Skin and Deformity of Nails132000COL7A1120120
Epilepsy, Nocturnal Frontal Lobe, 1600513CHRNA4118504
Factor XI Deficiency612416
Familial Mediterranean Fever, Autosomal Dominant134610MEFV608107
Fanconi Anemia, Complementation Group D1605724BRCA2600185
Fanconi Anemia, Complementation Group E600901FANCE613976
Fanconi Anemia, Complementation Group I609053FANCI611360
Fanconi Anemia, Complementation group N610832PALB2610355
Fever, Familial Lifelong Persistent *,#228400
Fibromatosis, Gingival, with Hypertrichosis and Mental Retardation605400
Frontotemporal Dysplasia and/or Amyotrophic Lateral Sclerosis 4616439TBK1604834
Fructose Intolerance, Hereditary229600ALDOB612724
Generalized Epilepsy with Febrile Seizures Plus, Type 7613863SCN9A603415
Hymen, Imperforate237100
Hyperalphalipoproteinemia 1143470CETP118470
Hypercarotenemia And Vitamin A Deficiency, Autosomal Recessive *277350
Hyperphenylalaninemia, BH4-Deficient, B233910
Hypophosphatemic Rickets, Autosomal Recessive, 1 241520DMP1600980
Ichthyosis, Congenital, Autosomal Recessive, 10615024PNPLA1612121
Immunodeficiency 69 *,#618963IFNG147570
Immunodeficiency with Defective T-Cell Response to Interleukin 1 *243110
Infantile Liver Failure Syndrome 2616483NBAS608025
Inflammatory Bowel Disease 28, Autosomal Recessive #613148IL10RA146933
Inflammatory Skin and Bowel Disease, Neonatal, 1 *,#614328ADAM17603639
Insulin-like Growth Factor I, Resistance to270450IGF1R147370
Intellectual Development Disorder with Short Stature, Facial Anomalies and Speech Defects *,#606220FBXL3605653
Intellectual Developmental Disorder 62618793DLG4602887
Internal Carotid Artery, Spontaneous Dissection of147820MTHFR607093
Joubert Syndrome 22615665PDE6D602676
Koolen-De Vries Syndrome610443KANSL1612452
Laurin-Sandrow Syndrome135750
Leber Congenital Amaurosis 7613829CRX602225
Lentigines150900
Lethal Congenital Contracture Syndrome 7616286CNTNAP1602346
Loeys-Dietz Syndrome 1609192
Loeys-Dietz Syndrome 5615582TGFB3190230
Lujan-Fryns Syndrome309520
Lymphoproliferative Syndrome, X-Linked, 2300635XIAP300079
Macrocephaly-Capillary Malformation602501
Mannose 6-Phosphate Receptor Recognition Defect, Lebanese Type *154570
Mental Retardation with Optic Atrophy, Facial Dysmorphism, Microcephaly, and Short Stature609037
Mental Retardation-Hypotonic Facies Syndrome, X-Linked, 1309580ATRX300032
Mental Retardation, X-Linked, Syndromic, Christianson Type300243SLC9A6300231
Metaphyseal Chondrodysplasia with Cone-Shaped Epiphyses, Normal Hair, and Normal Hands609989
Mitochondrial Complex I Deficiency, Nuclear Type 17 #618239NDUFAF6612392
Mitochondrial Complex III Deficiency, Nuclear Type 6 #615453CYC1123980
Mitochondrial Complex III Deficiency, Nuclear Type 7 #615824UQCC2614461
Mitochondrial Complex IV Deficiency, Nuclear Type 12 #619055PET100614770
Mitochondrial DNA Depletion Syndrome 11 #615084MGME1615076
Muscular Dystrophy-Dystroglycanopathy (Congenital With Impaired Intellectual Impairment), Type B, 1613155POMT1607423
Muscular Dystrophy-Dystroglycanopathy (Congenital with Mental Retardation), type B, 6608840LARGE1603590
Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 10608807TTN188840
Myoclonic Epilepsy, Congenital Deafness, Macular Dystrophy, and Psychiatric Disorders604363
Myofibrillar Myopathy 10 #619040SVIL604126
Myofibrillar Myopathy 11 #619178UNC45B611220
Myopathy, Lactic Acidosis, and Sideroblastic Anemia 2 #613561YARS2610957
Neurofaciodigitorenal Syndrome256690
Neutrophilic Dermatosis, Acute Febrile608068MEFV608107
Night Blindness, Congenital Stationary, Type 1E #614565GPR179614515
Night Blindness, Congenital Stationary, Type 1H #617024GNB3139130
Noonan Syndrome 4610733SOS1182530
Noonan Syndrome-Like Disorder with or without Juvenile Myelomonocytic Leukemia J613563CBL165360
Occult Macular Dystrophy613587RP1L1608581
Odontoonychodermal Dysplasia257980WNT10A606268
Orofaciodigital Syndrome, Type IV258860
Osteogenesis Imperfecta, Type XVI #616229CREB3L1616215
Otopalatodigital Syndrome, Type I311300FLNA300017
Paget Disease of bone 2, Early-onset602080
Pallister-Hall Syndrome146510
Parkinson Disease 7, Autosomal Recessive Early-Onset606324
Pentosuria260800
Peripheral Neuropathy, Autosomal Recessive, with or without Impaired Intellectual Development618124MCM3AP603294
Pigmentary Disorder, Reticulate, with Systemic Manifestations301220
Pitt-Hopkins Syndrome610954
Premature Ovarian Failure 2B * #300604
Progressive Familial Heart Block, Type IB #604559TRPM4606936
Pseudoachondroplasia177170COMP600310
Ramon Syndrome266270ELMO2606421
Retinopathy, Pigmentary, and Mental Retardation268050VPS13A605978
Rhizomelic Dysplasia, Scoliosis, and Retinitis Pigmentosa *610319
Roifman Syndrome616651RNU4ATAC601428
Short Stature and Facioauriculothoracic Malformations *609654
Short-Rib Thoracic Dysplasia 14 With Polydactyly #616546KIAA0586610178
Silver-Russell Syndrome180860
Skeletal Dysplasia, Rhizomelic, with Retinitis Pigmentosa *609047
Spasticity, Childhood-Onset, with Hyperglycinemia #616859GLRX5609588
Spinal Muscular Atrophy, Distal, Autosomal Recessive #607088VRK1602168
Spinocerebellar Ataxia 13605259KCNC3176264
Spinocerebellar Ataxia 35613908TGM6613900
Spinocerebellar Ataxia, Autosomal Recessive 2213200PMPCA613036
Spinocerebellar Ataxia, Autosomal Recessive 24617133UBA5610552
Spinocerebellar Degeneration and Corneal Dystrophy271310
Spondylocostal Dysostosis 3, Autosomal Recessive #609813LFNG602576
Chromosome 10q26 Deletion Syndrome609813
Spondylocostal Dysostosis, Autosomal Recessive 2 #608681MESP2605195
Spondyloepimetaphyseal Dysplasia, Maroteaux Type #184095TRPV4605427
Spondylometaphyseal Dysplasia, Megarbane-Dagher-Melki Type #613320PAM16614336
Stocco Dos Santos X-Linked Mental Retardation300434SHROOM4300579
Surfactant Metabolism Dysfunction, Pulmonary, 1265120SMDP1265120
Teeth, Supernumerary187100
Testes, Rudimentary273150
Thiopurines, Poor Metabolism of, 1610460TPMT187680
Tricuspid atresia605067NFATC1600489
Tubulointerstitial Kidney Disease, Autosomal Dominant, 2174000MUC1158340
Ulnar Hypoplasia191440
Variegate Porphyria176200PPOX600923
Vertebral, Cardiac, Renal, and Limb Defects Syndrome 2 #617661KYNU605197
Vibratory Urticaria125630ADGRE2606100
Vitamin K-Dependent Clotting Factors, Combined Deficiency of, 2 #607473VKORC1608547
Diseases first linked or mapped in Lebanese subjects
Alpha/Beta T-Cell Lymphoma with Gamma/Delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity #609889RAG1179615
Bardet-Biedl Syndrome 10 #615987BBS10610148
Charcot-Marie-Tooth Disease, Demyelinating, Type 4F #614895PRX605725
Charcot-Marie-Tooth Disease, Type 4H #609311FGD4611104
Deafness, Autosomal Recessive 13 #603098
Deafness, Autosomal Recessive 21 #603629TECTA602574
Deafness, Autosomal Recessive 9 #601071OTOF603681
Dihydropyrimidinase Deficiency #222748DPYS613326
Galloway-Mowat Syndrome 1 #251300WDR73; ZNF592616144; 613624
Hepatic Venoocclusive Disease with Immunodeficiency #235550SP110604457
Hydatidiform Mole, Recurrent, 1 #231090NLRP7609661
Hypercholesterolemia, Familial, 4 #603813LDLRAP1605747
Ichthyosis, Congenital, Autosomal Recessive 13 #617574
Immunodeficiency 12 #615468
Immunodeficiency 40 #616433DOCK2603122
Immunodeficiency 56 #615207IL21R605383
Lipodystrophy, Congenital Generalized, Type 2 #269700BSCL2606158
Pancreatic Agenesis 2 #615935PTF1A607194
Spinal Muscular Atrophy, Distal, Autosomal Recessive, 1 #604320IGHMBP2; REEP1600502; 609139
Weill-Marchesani Syndrome, Autosomal Recessive #277600ADAMTS10608990
Microphthalmia with Limb Anomalies #206920FNBP4; SMOC1615265; 608488
Geleophysic Dysplasia 1 #231050FBN1134797
Frank-Ter Haar Syndrome #249420SH3PXD2B613293
Orofaciodigital Syndrome XIV #615948C2CD3615944
Baller-Gerold Syndrome #218600RECQL4603780
* Diseases reported exclusively in Lebanese subjects. # Diseases that were first mapped in Lebanese subjects
Table
Table 2. Ten most prominent clinical features derived from HPO terms associated with Lebanese subjects in CTGA, ranked in decreasing order of occurrence. Ranking is based on the absolute number of individual subjects or subjects within a group, with each clinical feature.
Table 2. Ten most prominent clinical features derived from HPO terms associated with Lebanese subjects in CTGA, ranked in decreasing order of occurrence. Ranking is based on the absolute number of individual subjects or subjects within a group, with each clinical feature.
Individual Subject EntriesGroup Subject Entries
Intellectual disabilityDiabetes
Hearing impairmentCoronary Artery Disease
Global developmental delayAbnormal cholesterol levels
SeizuresFamilial Mediterranean Fever
Short statureAnemia
Muscular hypotoniaInflammatory bowel disease
Delayed speech and language developmentHypertension
Failure to thriveObesity
Periodic feverMyeloproliferative disorder
Atrial septal defectMyocardial Infarction
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bizzari, S.; Nair, P.; Deepthi, A.; Hana, S.; Al-Ali, M.T.; Megarbané, A.; El-Hayek, S. Catalogue for Transmission Genetics in Arabs (CTGA) Database: Analysing Lebanese Data on Genetic Disorders. Genes 2021, 12, 1518. https://doi.org/10.3390/genes12101518

AMA Style

Bizzari S, Nair P, Deepthi A, Hana S, Al-Ali MT, Megarbané A, El-Hayek S. Catalogue for Transmission Genetics in Arabs (CTGA) Database: Analysing Lebanese Data on Genetic Disorders. Genes. 2021; 12(10):1518. https://doi.org/10.3390/genes12101518

Chicago/Turabian Style

Bizzari, Sami, Pratibha Nair, Asha Deepthi, Sayeeda Hana, Mahmoud Taleb Al-Ali, André Megarbané, and Stephany El-Hayek. 2021. "Catalogue for Transmission Genetics in Arabs (CTGA) Database: Analysing Lebanese Data on Genetic Disorders" Genes 12, no. 10: 1518. https://doi.org/10.3390/genes12101518

APA Style

Bizzari, S., Nair, P., Deepthi, A., Hana, S., Al-Ali, M. T., Megarbané, A., & El-Hayek, S. (2021). Catalogue for Transmission Genetics in Arabs (CTGA) Database: Analysing Lebanese Data on Genetic Disorders. Genes, 12(10), 1518. https://doi.org/10.3390/genes12101518

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop